Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative

Alzheimer's and Dementia

Volumn 8, Issue 6, 2012, Pages 483-489

  Toledo, Jon B ^a   Toledo, Estefanía ^b   Weiner, Michael W ^c,d   Jack, Clifford R ^e   Jagust, William ^f   Lee, Virginia M Y ^a   Shaw, Leslie M ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Amyloid ; Blood pressure; Body mass index; Cortisol; PiB; Vascular risk factors

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; C REACTIVE PROTEIN; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; HYDROCORTISONE;

ALLELE; ALZHEIMER DISEASE; ARTICLE; B SCAN; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; GENOTYPE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 84867865831     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.08.008     Document Type: Article

References (57)

1. WHO. The global burden of disease: 2004 update. 2008, http://www.who.int/healthinfo/global-burden-disease/2004-report-update/en/index. html.
2. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, and H.M. Arrighi Forecasting the global burden of Alzheimer's disease Alzheimers Dement 3 2007 186 191
3. K.A. Jellinger, and J. Attems Prevalence of dementia disorders in the oldest-old: an autopsy study Acta Neuropathol 119 2010 421 433
4. H. Braak, and K. Del Tredici The pathological process underlying Alzheimer's disease in individuals under thirty Acta Neuropathol 121 2011 171 181
5. B. Dubois, H.H. Feldman, C. Jacova, J.L. Cummings, S.T. Dekosky, and P. Barberger-Gateau Revising the definition of Alzheimer's disease: a new lexicon Lancet Neurol 9 2010 1118 1127
6. N. Acosta-Baena, D. Sepulveda-Falla, C.M. Lopera-Gomez, M.C. Jaramillo-Elorza, S. Moreno, and D.C. Aguirre-Acevedo Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study Lancet Neurol 10 2011 213 220
7. C. Qiu, B. Winblad, and L. Fratiglioni The age-dependent relation of blood pressure to cognitive function and dementia Lancet Neurol 4 2005 487 499
8. J. Li, Y.J. Wang, M. Zhang, Z.Q. Xu, C.Y. Gao, and C.Q. Fang Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease Neurology 76 2011 1485 1491
9. K.J. Anstey, N. Cherbuin, M. Budge, and J. Young Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies Obes Rev 12 2011 e426 e437
10. J.A. Luchsinger, M.X. Tang, Y. Stern, S. Shea, and R. Mayeux Diabetes mellitus and risk of alzheimer's disease and dementia with stroke in a multiethnic cohort Am J Epidemiol 154 2001 635 641
11. C.M. Carlsson Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease J Alzheimers Dis 20 2010 711 722
12. R. Stewart, K. Masaki, Q.L. Xue, R. Peila, H. Petrovitch, and L.R. White A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study Arch Neurol 62 2005 55 60
13. G. Li, I.C. Rhew, J.B. Shofer, W.A. Kukull, J.C. Breitner, and E. Peskind Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study J Am Geriatr Soc 55 2007 1161 1167
14. J. Verghese, R.B. Lipton, C.B. Hall, G. Kuslansky, and M.J. Katz Low blood pressure and the risk of dementia in very old individuals Neurology 61 2003 1667 1672
15. S.P. Kennelly, B.A. Lawlor, and R.A. Kenny Blood pressure and the risk for dementia - a double edged sword Ageing Res Rev 8 2009 61 70
16. A. Solomon, I. Kareholt, T. Ngandu, B. Winblad, A. Nissinen, and J. Tuomilehto Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study Neurology 68 2007 751 756
17. W.L. Xu, A.R. Atti, M. Gatz, N.L. Pedersen, B. Johansson, and L. Fratiglioni Midlife overweight and obesity increase late-life dementia risk Neurology 76 2011 1568 1574
18. C. Qiu, W. Xu, and L. Fratiglioni Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention J Alzheimers Dis 20 2010 689 697
19. L.J. Launer, T. Hughes, B. Yu, K. Masaki, H. Petrovitch, and G.W. Ross Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study Hypertension 55 2010 1352 1359
20. B.K. Lee, T.A. Glass, G.S. Wand, M.J. McAtee, K. Bandeen-Roche, and K.I. Bolla Apolipoprotein E genotype, cortisol, and cognitive function in community-dwelling older adults Am J Psychiatry 165 2008 1456 1464
21. C.W. Huang, C.C. Lui, W.N. Chang, C.H. Lu, Y.L. Wang, and C.C. Chang Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease J Clin Neurosci 16 2009 1283 1286
22. P.W. Landfield, E.M. Blalock, K.C. Chen, and N.M. Porter A new glucocorticoid hypothesis of brain aging: implications for Alzheimer's disease Curr Alzheimer Res 4 2007 205 212
23. L.M. Shaw, M. Korecka, C.M. Clark, V.M. Lee, and J.Q. Trojanowski Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics Nat Rev Drug Discov 6 2007 295 303
24. S.G. Mueller, M.W. Weiner, L.J. Thal, R.C. Petersen, C.R. Jack, and W. Jagust Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimers Dement 1 2005 55 66
25. R.C. Petersen, P.S. Aisen, L.A. Beckett, M.C. Donohue, A.C. Gamst, and D.J. Harvey Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 2010 201 209
26. A.D. Association Diagnosis and classification of diabetes mellitus Diabetes Care 34 Suppl 1 2011 S62 S69
27. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C. Clark, P. Aisen, and R. Petersen Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann Neurol 65 2009 403 413
28. C.A. Mathis, Y. Wang, D.P. Holt, G.F. Huang, M.L. Debnath, and W.E. Klunk Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents J Med Chem 46 2003 2740 2754
29. W.J. Jagust, D. Bandy, K. Chen, N.L. Foster, S.M. Landau, and C.A. Mathis The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core Alzheimers Dement 6 2010 221 229
30. V. Yohai, W.A. Stahel, and R.H. Zamar A procedure for robust estimation and inference in linear regression W.A. Stahel, S.W. Weisberg, Directions in Robust Statistics and Diagnostics PI 1991 Springer-Verlag New York, NY
31. W.N. Venables, and B.D. Ripley Modern applied statistics with S Fourth edition 2002 Springer Verlag New York, NY
32. Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, et al. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging (in press).
33. R. Peila, B.L. Rodriguez, and L.J. Launer Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies Diabetes 51 2002 1256 1262
34. L.B. Hoffman, J. Schmeidler, G.T. Lesser, M.S. Beeri, D.P. Purohit, and H.T. Grossman Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons Neurology 72 2009 1720 1726
35. J.A. Luchsinger, B. Patel, M.X. Tang, N. Schupf, and R. Mayeux Measures of adiposity and dementia risk in elderly persons Arch Neurol 64 2007 392 398
36. D.R. Gustafson, K.M. Backman, M.M. Waern, S.M. Ostling, X.M. Guo, and P.P. Zandi Adiposity indicators and dementia over 32 years in Sweden Neurology 73 2009 1559 1566
37. J.A. Schneider, P.A. Boyle, Z. Arvanitakis, J.L. Bienias, and D.A. Bennett Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons Ann Neurol 62 2007 59 66
38. J.C. Troncoso, A.B. Zonderman, S.M. Resnick, B. Crain, O. Pletnikova, and R.J. O'Brien Effect of infarcts on dementia in the Baltimore longitudinal study of aging Ann Neurol 64 2008 168 176
39. H. Dolan, B. Crain, J. Troncoso, S.M. Resnick, A.B. Zonderman, and R.J. Obrien Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort Ann Neurol 68 2010 231 240
40. M.A. Koike, K.N. Green, M. Blurton-Jones, and F.M. LaFerla Oligemic hypoperfusion differentially affects tau and amyloid-[beta] Am J Pathol 177 2010 300 310
41. X. Zhang, K. Zhou, R. Wang, J. Cui, S.A. Lipton, and F.F. Liao Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation J Biol Chem 282 2007 10873 10880
42. R.D. Bell, and B.V. Zlokovic Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease Acta Neuropathol 118 2009 103 113
43. M.T. Gentile, R. Poulet, A.D. Pardo, G. Cifelli, A. Maffei, and C. Vecchione [beta]-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension Neurobiol Aging 30 2009 222 228
44. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, and L. Nilsson 15-year longitudinal study of blood pressure and dementia Lancet 347 1996 1141 1145
45. J. Li, M. Zhang, Z.Q. Xu, C.Y. Gao, C.Q. Fang, and J. Deng Vascular risk aggravates the progression of Alzheimer's disease in a Chinese cohort J Alzheimers Dis 20 2010 491 500
46. K.M. Bellew, J.G. Pigeon, P.E. Stang, W. Fleischman, R.M. Gardner, and W.W. Baker Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type Alzheimer Dis Assoc Disord 18 2004 208 213
47. Z. Arvanitakis, J.A. Schneider, R.S. Wilson, Y. Li, S.E. Arnold, and Z. Wang Diabetes is related to cerebral infarction but not to AD pathology in older persons Neurology 67 2006 1960 1965
48. S. Takeda, N. Sato, K. Uchio-Yamada, K. Sawada, T. Kunieda, and D. Takeuchi Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes Proc Natl Acad Sci U S A 107 2010 7036 7041
49. K.N. Green, L.M. Billings, B. Roozendaal, J.L. McGaugh, and F.M. LaFerla Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimer's disease J Neurosci 26 2006 9047 9056
50. Y. Wang, M. Li, J. Tang, M. Song, X. Xu, and J. Xiong Glucocorticoids facilitate astrocytic amyloid-{beta} peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-{beta}-degrading proteases Endocrinology 152 2011 2704 2715
51. A. Kadir, A. Marutle, D. Gonzalez, M. Schöll, O. Almkvist, and M. Mousavi Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease Brain 134 2011 301 317
52. P. Edison, H.A. Archer, A. Gerhard, R. Hinz, N. Pavese, and F.E. Turkheimer Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study Neurobiol Dis 32 2008 412 419
53. A. Okello, P. Edison, H.A. Archer, F.E. Turkheimer, J. Kennedy, and R. Bullock Microglial activation and amyloid deposition in mild cognitive impairment: a PET study Neurology 72 2009 56 62
54. C.A. Wiley, B.J. Lopresti, S. Venneti, J. Price, W.E. Klunk, and S.T. DeKosky Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease Arch Neurol 66 2009 60 67
55. C. Reitz, M.X. Tang, J. Luchsinger, and R. Mayeux Relation of plasma lipids to Alzheimer disease and vascular dementia Arch Neurol 61 2004 705 714
56. R. Stewart, L.R. White, Q.L. Xue, and L.J. Launer Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study Arch Neurol 64 2007 103 107
57. T. Ninomiya, T. Ohara, Y. Hirakawa, D. Yoshida, Y. Doi, and J. Hata Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama Study Hypertension 58 2011 22 28